International Patent: ADENO-ASSOCIATED VIRUS (AAV) -MEDIATED SHANK3 EXPRESSION AND USES THEREOF

GENEVA, July 1 -- SHENZHEN REBORNGENE THERAPEUTICS CO. LTD. filed a patent application (CN2024/138067) for “ADENO-ASSOCIATED VIRUS (AAV) -MEDIATED SHANK3 EXPRESSION AND USES THEREOF”. With publication no. WO/2026/123194, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/86

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....